Evolent Health, Inc. announced the appointment of Dr. Von Nguyen as its new Chief Medical Officer, effective January 1, 2025. Dr. Nguyen joined Evolent as Chief Clinical Officer in July 2024, bringing extensive experience in population health and clinical innovation.
Dr. Nguyen's background includes serving as clinical lead for population health at Google, Chief Medical Officer at Blue Cross North Carolina, and senior advisory roles at the Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services. His expertise is expected to enhance Evolent's clinical quality programs and accelerate efforts to create a higher-quality healthcare system.
Dr. Nguyen will succeed Dr. Andrew Hertler, who will transition to a part-time role as senior advisor and CMO emeritus, focusing on advancing innovation for Evolent's oncology management solution. This leadership transition aims to build on Dr. Hertler's legacy while bringing fresh perspectives to the company's clinical strategy.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.